Skip to content
Home/Companies/Pharma/Nycomed

Nycomed

Pharma·Switzerland·Exited 2011·Held 9yr
Entry
2002
Hold
9yr
Exit
2011

Who owns Nycomed?

Nycomed was owned by Nordic Capital through Nordic Capital (early funds) (1991 vintage) from 2002 to 2011, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-18

Nordic Capital
Investor
Nordic Capital
Nordic Capital (early funds) · 1991 · Buyout

Key facts

HQSwitzerland
SectorPharma
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2011

More from Nordic Capital (early funds)

Other portfolio companies in the same fund.

Bufab
Exited 2014
IndustrialsSweden· 2005
Cloetta
Exited 2013
ConsumerSweden· 2005
FinnvedenBulten
Exited 2011
MobilitySweden· 2005
Fougera Pharmaceuticals Inc. (formerly Nycomed US Inc.)
Exited 2012
PharmaUS· 2005
to
Kompan
Exited 2014
ConsumerDenmark· 2005
to
Luvata
Exited 2014
IndustrialsFinland· 2005
to

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track Nycomed

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Nycomed?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Nycomed.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue